Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by Canuck51on Mar 30, 2015 4:22pm
174 Views
Post# 23578493

RE:the email

RE:the emailm8magic - Let's put this in perspective. 
  1. There is no delays present. The company has always stated that they will be generating revenue in Q2. This will still happen. You may have had a personal perception in this regard, but there are no red flags here.
  2. Show me in that email where Mr. Aman mentioned 2nd order. Again another perception of yours. You know that a CEO will never leak proprietary information in an email to anyone, right?
  3. "Are you currently pursuing further relationships to develop with provincial government health plans?
    -          We will always look for ways to separate ourselves from our competitors but at this point it is difficult for me to comment on this.
    Read more at https://www.stockhouse.com/companies/bullboard/v.nph/vanc-pharmaceuticals-inc#Z3j7Y29X5IlTUip6.99" Hint was given with this statement!
  4. Last but not least, we know you took your profit out and left a small position in NPH and moved on the V.NSP, V.YFI and V.MZI. Now would it be safe to say that you've cashed out of some of all of the above mentioned three and now you want to jump back in to NPH.V. The price must be a little too high for your required rentry so you have to throw your digs in. No offense meant m8, ok.
We've all seen you do this before m8magic so your motives here are suspect IMO.

Either way I wish you luck in all your endeavors, as well as all other NPH.V longs.

Last point I will make is we all see the valueable DD that has been done by many seasoned investors here and the writing on the wall is nothing but clear blue skies in the long run. Relax and let it happen. The day to day antics that happen here on this board really don't matter in the grand scheme of things and NPH will prevail!

Cheers

m8magic wrote: Cunuck51 recieved is a downer imo...shows huge time delays before anything is for sale...heck even the first order is three weeks away of being cleared from h/c customs...the second isn;t even ordered yet...


Bullboard Posts